<DOC>
	<DOCNO>NCT01060605</DOCNO>
	<brief_summary>Numerous change original Edmonton protocol propose attempt improve still unsatisfactory long-term function ITA . Rapamycin may blunt early inflammatory response islet transplantation liver , thus favor islet engraftment . Aim investigator study evaluate effect pre-transplant treatment rapamycin patient type 1 diabetes receive islet transplant alone immunosuppression accord Edmonton protocol .</brief_summary>
	<brief_title>Pre Transplant Rapamycin Treatment Islet Transplantation Alone</brief_title>
	<detailed_description>Pre-transplant rapamycin administer least four week prior first islet infusion dose 0.1 mg/kg ( target trough level : 8-10 ng/mL ) . During pre-transplant rapamycin treatment rapamycin trough level , renal liver function , white blood cell count , total lymphocyte lymphocytes subpopulation , hemoglobin , fibrinogen , cross-linked fibrin degradation product , C-reactive protein , exogenous insulin requirement every week first month , monthly thereafter measure . Induction maintenance immunosuppressive regimen islet infusion administer accord Edmonton protocol ( daclizumab , rapamycin , target trough level : 12-15 ng/mL first 3 month 10-12 ng/mL thereafter tacrolimus 2 mg/day , target trough level : 4-6 ng/mL ) . Islets infuse liver portal vein local anesthesia Portography perform infusion . The islet function evaluate measure fast C-pep , EIR , HbA1c , immediately first islet infusion subsequently every day first week , weekly first month ; every month last islet infusion first year every 6 month thereafter .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>type 1 diabetes â‰¥5 year type 1 diabetes hypoglycaemia unawareness progression chronic complication diabetes despite intensive insulin regimen overt kidney disease chronic liver disease hepatic haemangioma severe cardiomyopathy untreated coronary artery disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>islet transplantation</keyword>
	<keyword>insulin independence</keyword>
	<keyword>C-peptide secretion</keyword>
</DOC>